
	2020		2019		2018
Net sales
Oral, Personal and Home Care
North America(1)	$	3,741	$	3,424	$	3,348
Latin America	3,418		3,606		3,605
Europe	2,747		2,450		2,502
Asia Pacific	2,701		2,707		2,734
Africa/Eurasia	981		981		967
Total Oral, Personal and Home Care	13,588		13,168		13,156
Pet Nutrition(2)	2,883		2,525		2,388
Total Net sales	$	16,471	$	15,693	$	15,544

(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,447, $3,166 and $3,091 in 2020, 2019 and 2018, respectively.

(2) Net sales in the U.S. for Pet Nutrition were $1,712, $1,441 and $1,304 in 2020, 2019 and 2018, respectively.


	2020		2019		2018
Operating profit
Oral, Personal and Home Care
North America	$	988	$	982	$	1,037
Latin America	975		963		995
Europe	652		624		634
Asia Pacific	773		749		777
Africa/Eurasia	206		187		173
Total Oral, Personal and Home Care	3,594		3,505		3,616
Pet Nutrition	793		703		680
Corporate	(502)		(654)		(602)
Total Operating profit	$	3,885	$	3,554	$	3,694


	2020		2019		2018
Capital expenditures
Oral, Personal and Home Care
North America	$	65	$	43	$	53
Latin America	104		90		131
Europe	41		42		39
Asia Pacific	51		40		75
Africa/Eurasia	13		8		11
Total Oral, Personal and Home Care	274		223		309
Pet Nutrition	56		41		35
Corporate	79		71		92
Total Capital expenditures	$	409	$	335	$	436


	2020		2019		2018
Depreciation and amortization
Oral, Personal and Home Care
North America	$	101	$	94	$	88
Latin America	81		84		82
Europe	94		72		70
Asia Pacific	95		100		103
Africa/Eurasia	9		8		8
Total Oral, Personal and Home Care	380		358		351
Pet Nutrition	58		55		53
Corporate	101		106		107
Total Depreciation and amortization	$	539	$	519	$	511


	2020		2019		2018
Identifiable assets
Oral, Personal and Home Care
North America	$	4,132	$	3,576	$	3,310
Latin America	2,251		2,384		2,225
Europe	5,386		5,104		2,883
Asia Pacific	2,272		2,155		2,148
Africa/Eurasia	605		590		502
Total Oral, Personal and Home Care	14,646		13,809		11,068
Pet Nutrition	1,210		1,175		1,033
Corporate(1)	64		50		60
Total Identifiable assets(2)	$	15,920	$	15,034	$	12,161

(1)In 2020, Corporate identifiable assets primarily consist of investments in equity securities (95%). In 2019, Corporate identifiable assets primarily consist of derivative instruments (2%) and investments in equity securities (92%). In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%).

(2)Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $10,911 in 2020, one-third of total long-lived assets of $10,192 in 2019, and one-half of total long-lived assets of $8,259 in 2018.